Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression—real-world clinical practice

por Aviles Bueno, Beatriz, Soler, Maria Jose, Perez-Belmonte, Luis, Jimenez Millan, Anabel, Rivas Ruiz, Francisco, Garcia de Lucas, Maria Dolores
Publicado 2022

Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study

por García de Lucas, María Dolores, Caballero, Irene, Fernández-García, José Carlos, Domínguez-Rodríguez, Manuel, Moreno-Moreno, Paloma, Jiménez-Millán, Anabel, Botana-López, Manuel, Avilés, Beatriz, Merino-Torres, Juan Francisco, Soto, Alfonso, Tejera, Cristina, Morales, Cristóbal
Publicado 2023